MNKD
MNKD
NASDAQ · Biotechnology

Mannkind Corp

$2.28
-0.01 (-0.44%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +1,286.4% upside
Low Target $20.51
Average Target $31.61
High Target $34.61
Current Price $2.28
Current
$2.28
Target
$31.61
$20.51 $31.61 avg $34.61
Scenario Analysis
Bear Case
$20.51
799.6%
Low target
Base Case
$31.61
+1,286.4%
Avg target
Bull Case
$34.61
+1,418.0%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$6.51
-65.0% from high
52-Week Low
$2.81
+-18.9% from low
Target vs 52W High
$31.61
+385.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%